Viewing Study NCT00555061


Ignite Creation Date: 2025-12-24 @ 1:04 PM
Ignite Modification Date: 2026-02-11 @ 6:57 AM
Study NCT ID: NCT00555061
Status: COMPLETED
Last Update Posted: 2016-12-28
First Post: 2007-11-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: TOC106489
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators